Among them, ABCG2 was discovered in the late 1990s by Doyle et al. in the MCF-7 drug-resistant breast cancer cell subline and, for this reason, initially named Breast Cancer Resistance Protein (BCRP) [20]. The gene discussed is ABCG2; the disease is breast carcinoma.